Nortriptyline HCl Capsules recall: CGMP Deviations
Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro…
Why was Nortriptyline HCl Capsules recalled?
CGMP deviations.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
AC05096, AC05098, and AC05099; Exp 10/31/2022
- Product
- Nortriptyline HCl Capsules, USP equivalent to 10mg base Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro…
- Recalling firm
- Taro Pharmaceuticals U.S.A., Inc.
- Quantity
- 44,256 bottles
- Distribution
- Nationwide
- Recall date
- February 10, 2021
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)